• Nausea

Droperidol Generic Name & Formulations

General Description

Droperidol 2.5mg/mL; soln for IV or IM inj.

Pharmacological Class


How Supplied

Contact supplier.

Droperidol Indications


To reduce incidence of nausea and vomiting associated with surgical and diagnostic procedures.

Droperidol Dosage and Administration


Max initial dose: 2.5mg IM or slow IV; may give additional 1.25mg doses to achieve desired effect.


<2yrs: not recommended. ≥2yrs: max initial dose: 0.1mg/kg.

Droperidol Contraindications


QT prolongation (including congenital long QT syndrome).

Droperidol Boxed Warnings

Not Applicable

Droperidol Warnings/Precautions


Perform ECG prior to administration to determine if prolonged QT interval present; if prolonged, do not administer unless treatment outweighs risks; if treating, monitor for arrhythmias: perform ECG prior to treatment and 2–3hrs after completion. Risk factors for QT prolongation: CHF, bradycardia, cardiac hypertrophy, hypokalemia, hypomagnesemia, >65yrs, alcohol abuse. Pheochromocytoma. Hepatic or renal impairment. Elderly. Debilitated. Critically ill. Labor & delivery: not recommended. Pregnancy (Cat.C). Nursing mothers.

Droperidol Pharmacokinetics

See Literature

Droperidol Interactions


Risk of QT prolongation with concomitant Class I and III antiarrhythmics, MAOIs, antimalarials, calcium channel blockers, benzodiazepines, volatile anesthetics, IV opiates, other drugs that prolong QT interval. Caution with drugs that induce hypokalemia, hypomagnesemia (eg, diuretics, laxatives). Additive effects with CNS depressants (eg, barbiturates, tranquilizers, opioids, general anesthetics). Possible hypertension with concomitant fentanyl citrate inj.

Droperidol Adverse Reactions

Adverse Reactions

Hypotension, tachycardia, dysphoria, drowsiness, restlessness, hyperactivity, anxiety, QT prolonation, torsade de pointes, cardiac arrest, ventricular tachycardia, neuroleptic malignant syndrome, post-op hallucinatory episodes.

Droperidol Clinical Trials

See Literature

Droperidol Note


Formerly known under the brand name Inapsine.

Droperidol Patient Counseling

See Literature